Trans-Chalcone prevents VEGF expression and retinal neovascularization in the ischemic retina

Folami Lamoke Powell, Mohamed Labazi, Annalisa Montemari, Giovanni Parisi, Monica Varano, Manuela Bartoli

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Retinal neovascularization (RNV) is a critical pathological event and a major cause of blindness. Vascular inflammation and oxidative stress have been shown to play a key role in the induction and progression of RNV. Trans-Chalcone-derived flavonoids have been previously shown to be negative modulators of oxidative stress and inflammatory responses as well as tumor angiogenesis. In this study, we characterized the effects of the flavonoid trans-Chalcone in preventing RNV in a model of ischemic retinopathy. Ischemic retinopathy was induced in neonatal mice subjected to oxygen-induced retinopathy. Trans-Chalcone was administered intra-peritoneum at the dose of 25 mg/kg/day. Vascular density was assessed by morphometric analysis of flat mounted retinas stained with Texas red-Isolectin B4. Western blotting analysis was conducted to determine protein levels of vascular endothelial growth factor (VEGF), inter-cellular adhesion molecule 1 (ICAM-1) and the transcriptional activators' signal transducer and activator of transcription 3 (STAT3) and nuclear factor kappa beta (NF-κB). Treatment with trans-Chalcone significantly inhibited RNV in the ischemic retina, as shown by decreased number of neovascular tufts. Trans-Chalcone also blocked ischemia-induced VEGF and ICAM-1 expression and this effect correlated with inhibition of activated STAT3 and NF-κB. Our results show that trans-Chalcone effectively prevents RNV in the murine retina thus suggesting that Chalcone-derived flavonoids may be beneficial in preventing pathological neovascularization in the ischemic retina.

Original languageEnglish (US)
Pages (from-to)350-354
Number of pages5
JournalExperimental eye research
Volume93
Issue number4
DOIs
StatePublished - Oct 1 2011

Fingerprint

Retinal Neovascularization
Chalcone
Vascular Endothelial Growth Factor A
Retina
Flavonoids
STAT3 Transcription Factor
Blood Vessels
Oxidative Stress
Pathologic Neovascularization
Peritoneum
Blindness
Lectins
Ischemia
Western Blotting
Oxygen
Inflammation

Keywords

  • Flavonoids
  • Retinal neovascularization
  • Trans-Chalcone
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Trans-Chalcone prevents VEGF expression and retinal neovascularization in the ischemic retina. / Powell, Folami Lamoke; Labazi, Mohamed; Montemari, Annalisa; Parisi, Giovanni; Varano, Monica; Bartoli, Manuela.

In: Experimental eye research, Vol. 93, No. 4, 01.10.2011, p. 350-354.

Research output: Contribution to journalArticle

Powell, Folami Lamoke ; Labazi, Mohamed ; Montemari, Annalisa ; Parisi, Giovanni ; Varano, Monica ; Bartoli, Manuela. / Trans-Chalcone prevents VEGF expression and retinal neovascularization in the ischemic retina. In: Experimental eye research. 2011 ; Vol. 93, No. 4. pp. 350-354.
@article{91f5d48e4c11414ba0e3f193d0ec7bf2,
title = "Trans-Chalcone prevents VEGF expression and retinal neovascularization in the ischemic retina",
abstract = "Retinal neovascularization (RNV) is a critical pathological event and a major cause of blindness. Vascular inflammation and oxidative stress have been shown to play a key role in the induction and progression of RNV. Trans-Chalcone-derived flavonoids have been previously shown to be negative modulators of oxidative stress and inflammatory responses as well as tumor angiogenesis. In this study, we characterized the effects of the flavonoid trans-Chalcone in preventing RNV in a model of ischemic retinopathy. Ischemic retinopathy was induced in neonatal mice subjected to oxygen-induced retinopathy. Trans-Chalcone was administered intra-peritoneum at the dose of 25 mg/kg/day. Vascular density was assessed by morphometric analysis of flat mounted retinas stained with Texas red-Isolectin B4. Western blotting analysis was conducted to determine protein levels of vascular endothelial growth factor (VEGF), inter-cellular adhesion molecule 1 (ICAM-1) and the transcriptional activators' signal transducer and activator of transcription 3 (STAT3) and nuclear factor kappa beta (NF-κB). Treatment with trans-Chalcone significantly inhibited RNV in the ischemic retina, as shown by decreased number of neovascular tufts. Trans-Chalcone also blocked ischemia-induced VEGF and ICAM-1 expression and this effect correlated with inhibition of activated STAT3 and NF-κB. Our results show that trans-Chalcone effectively prevents RNV in the murine retina thus suggesting that Chalcone-derived flavonoids may be beneficial in preventing pathological neovascularization in the ischemic retina.",
keywords = "Flavonoids, Retinal neovascularization, Trans-Chalcone, Vascular endothelial growth factor",
author = "Powell, {Folami Lamoke} and Mohamed Labazi and Annalisa Montemari and Giovanni Parisi and Monica Varano and Manuela Bartoli",
year = "2011",
month = "10",
day = "1",
doi = "10.1016/j.exer.2011.02.007",
language = "English (US)",
volume = "93",
pages = "350--354",
journal = "Experimental Eye Research",
issn = "0014-4835",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Trans-Chalcone prevents VEGF expression and retinal neovascularization in the ischemic retina

AU - Powell, Folami Lamoke

AU - Labazi, Mohamed

AU - Montemari, Annalisa

AU - Parisi, Giovanni

AU - Varano, Monica

AU - Bartoli, Manuela

PY - 2011/10/1

Y1 - 2011/10/1

N2 - Retinal neovascularization (RNV) is a critical pathological event and a major cause of blindness. Vascular inflammation and oxidative stress have been shown to play a key role in the induction and progression of RNV. Trans-Chalcone-derived flavonoids have been previously shown to be negative modulators of oxidative stress and inflammatory responses as well as tumor angiogenesis. In this study, we characterized the effects of the flavonoid trans-Chalcone in preventing RNV in a model of ischemic retinopathy. Ischemic retinopathy was induced in neonatal mice subjected to oxygen-induced retinopathy. Trans-Chalcone was administered intra-peritoneum at the dose of 25 mg/kg/day. Vascular density was assessed by morphometric analysis of flat mounted retinas stained with Texas red-Isolectin B4. Western blotting analysis was conducted to determine protein levels of vascular endothelial growth factor (VEGF), inter-cellular adhesion molecule 1 (ICAM-1) and the transcriptional activators' signal transducer and activator of transcription 3 (STAT3) and nuclear factor kappa beta (NF-κB). Treatment with trans-Chalcone significantly inhibited RNV in the ischemic retina, as shown by decreased number of neovascular tufts. Trans-Chalcone also blocked ischemia-induced VEGF and ICAM-1 expression and this effect correlated with inhibition of activated STAT3 and NF-κB. Our results show that trans-Chalcone effectively prevents RNV in the murine retina thus suggesting that Chalcone-derived flavonoids may be beneficial in preventing pathological neovascularization in the ischemic retina.

AB - Retinal neovascularization (RNV) is a critical pathological event and a major cause of blindness. Vascular inflammation and oxidative stress have been shown to play a key role in the induction and progression of RNV. Trans-Chalcone-derived flavonoids have been previously shown to be negative modulators of oxidative stress and inflammatory responses as well as tumor angiogenesis. In this study, we characterized the effects of the flavonoid trans-Chalcone in preventing RNV in a model of ischemic retinopathy. Ischemic retinopathy was induced in neonatal mice subjected to oxygen-induced retinopathy. Trans-Chalcone was administered intra-peritoneum at the dose of 25 mg/kg/day. Vascular density was assessed by morphometric analysis of flat mounted retinas stained with Texas red-Isolectin B4. Western blotting analysis was conducted to determine protein levels of vascular endothelial growth factor (VEGF), inter-cellular adhesion molecule 1 (ICAM-1) and the transcriptional activators' signal transducer and activator of transcription 3 (STAT3) and nuclear factor kappa beta (NF-κB). Treatment with trans-Chalcone significantly inhibited RNV in the ischemic retina, as shown by decreased number of neovascular tufts. Trans-Chalcone also blocked ischemia-induced VEGF and ICAM-1 expression and this effect correlated with inhibition of activated STAT3 and NF-κB. Our results show that trans-Chalcone effectively prevents RNV in the murine retina thus suggesting that Chalcone-derived flavonoids may be beneficial in preventing pathological neovascularization in the ischemic retina.

KW - Flavonoids

KW - Retinal neovascularization

KW - Trans-Chalcone

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=80055038350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80055038350&partnerID=8YFLogxK

U2 - 10.1016/j.exer.2011.02.007

DO - 10.1016/j.exer.2011.02.007

M3 - Article

C2 - 21354136

AN - SCOPUS:80055038350

VL - 93

SP - 350

EP - 354

JO - Experimental Eye Research

JF - Experimental Eye Research

SN - 0014-4835

IS - 4

ER -